Interestingly, the [CD20×NKG2D#24] bibody with low NK cell activation capacity in terms of CD69 induction was not able to increase tumor cell lysis in combination with monoclonal antibodies (Supplementary Figure 2). This evidence concerns the gene CD69 and neoplasm.